Table 1 Demographic characteristics and baseline evaluation data according to randomisation group
Group randomised to wear hAFO then plsAFO | Group randomised to wear plsAFO then hAFO | |
|---|---|---|
Age (years) | 67.5 (18.2) | 47.4 (13.5) |
Males/Females (n) | 5/5 | 3/7 |
Peripheral neuropathy / NMD (n) | 8/2 | 6/4 |
Time since onset (months) | 66.5 (140.5) | 60 (116.8) |
Dorsiflexor strength | 3.0 (1.0) | 2.5 (1.8) |
Evertor strength | 3.0 (0) | 3.5 (1.0) |
Plantarflexor strength | 4.0 (1) | 5 (1.8) |
6MWT (noAFO) | 355.5 (110.8) | 321.0 (89.5) |
TUG (noAFO) | 10.0 (1.6) | 9.6 (4.2) |